Full Year 2024 DSM-Firmenich AG Earnings Call Transcript
Key Points
- DSM Firmenich AG (DSMFF) reported a strong organic sales growth of 6% for 2024, with a significant step-up in EBITDA.
- The company successfully delivered on its cost synergies, contributing to a EUR350 million EBITDA improvement.
- DSM Firmenich AG (DSMFF) announced a EUR1 billion share buyback, reflecting confidence in its earnings and cash flow generation.
- The company has a robust innovation pipeline, particularly in areas like preventative healthcare and healthier food, which are expected to drive future growth.
- DSM Firmenich AG (DSMFF) achieved a high employee engagement score of 79%, indicating strong internal alignment and morale.
- The company faces challenges with vitamin price volatility, which has impacted its financial performance in the past.
- There is a noted softness in the Beauty and Care segment, particularly in Asia, which may affect future growth in this area.
- The divestment process for Animal Nutrition and Health (ANH) is ongoing, with uncertainties around timing and valuation.
- DSM Firmenich AG (DSMFF) is experiencing input inflation pressures, particularly in natural ingredients, which could impact margins.
- The company has not provided specific guidance on normalized vitamin pricing, creating some uncertainty for investors.
Good morning. Thank you for joining today's call. I'm sitting here with Dimitri de Vreeze, our CEO; and Ralf Schmeitz, our CFO. We published this morning a press release with our 2024 full year results together with the presentation to investors, which you both can find on our website. You can also find the disclaimers about forward-looking statements.
Following Dimitri's and Ralf's presentations, we will open the line for questions. Important to remind the sell-side analysts who want to ask questions have to register via the questioners link, which they can find on our website in the financial calendar.
And with that, Dimitri, you can start.
Thank you. Thank you, Dave, and welcome to all 2024, but I would like to put that into perspective. And I think this slide you've seen before from all of us, and it is our journey slide. We started with the dream, we merged two
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
